NeuroPace Files 8-K: Other Events & Financials
Ticker: NPCE · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1528287
| Field | Detail |
|---|---|
| Company | Neuropace Inc (NPCE) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-K, regulatory-disclosure
Related Tickers: NPCE
TL;DR
NeuroPace filed an 8-K, check for updates on events and financials.
AI Summary
NeuroPace, Inc. filed an 8-K on February 20, 2025, reporting on other events and financial statements. The filing does not contain specific details about new agreements, material events, or financial figures within the provided text.
Why It Matters
This 8-K filing indicates NeuroPace is providing updates to the SEC, which could include material information relevant to investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific details of material events, making the immediate risk assessment low.
Key Players & Entities
- NeuroPace, Inc. (company) — Registrant
- February 20, 2025 (date) — Date of earliest event reported
- 455 N. Bernardo Avenue (location) — Principal executive offices address
- Mountain View, CA (location) — Principal executive offices city and state
- 94043 (location) — Principal executive offices zip code
- (650) 237-2700 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by NeuroPace, Inc. in this 8-K filing?
The provided text for the 8-K filing does not specify the details of the 'Other Events' being reported.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 20, 2025.
Where are NeuroPace, Inc.'s principal executive offices located?
NeuroPace, Inc.'s principal executive offices are located at 455 N. Bernardo Avenue, Mountain View, CA 94043.
What is the Commission File Number for NeuroPace, Inc.'s 8-K filing?
The Commission File Number for NeuroPace, Inc.'s 8-K filing is 001-40337.
Does this filing include specific financial statements or exhibits?
The filing is categorized to include 'Financial Statements and Exhibits', but the specific content of these is not detailed in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding NeuroPace Inc (NPCE).